MedPath

Performance Evaluation Study for Clearblue Pregnancy Test

Completed
Conditions
Pregnancy
Registration Number
NCT01077583
Lead Sponsor
SPD Development Company Limited
Brief Summary

The purpose of this study is to collect urine samples and dating scan information from women who wish to become pregnant. Urine samples will be tested in the laboratory with the Clearblue Pregnancy Test and the results correlated with volunteer information.

Detailed Description

Approximately 800 female volunteers wishing to become pregnant will be recruited locally around 5 trial centers within the US.

Daily urine samples and gestational age dating scan information obtained from the study will be used in laboratory tests to assess the accuracy of the Clearblue Pregnancy Test. Product assessment will involve testing of early morning urine samples collected by women during the cycle in which they conceived. Urine samples will be collected pre-conception to the end of the second trimester.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
800
Inclusion Criteria
  • Provide written informed consent to participate in the study and agree to comply with study procedures.
  • Has menstrual bleeds.
  • Seeking to become pregnant.
  • Intend to seek medical care during pregnancy.
Exclusion Criteria
  • Has positive pregnancy test on screening.
  • Has received medical treatment for infertility or is participating in an assisted fertility program.
  • Known condition to contra-indicate pregnancy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The agreement of the Clearblue Pregnancy Test result with Duration of Pregnancy.1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Radiant Research Inc

🇺🇸

San Antonio, Texas, United States

Radiant Research, Inc.

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath